tiludronate
Selected indexed studies
- Tiludronate. (, 2006) [PMID:30000683]
- Tiludronate. A new treatment for an old ailment: Paget's disease of bone. (Expert Opin Pharmacother, 1999) [PMID:11249559]
- Tiludronate: bone pharmacology and safety. (Bone, 1995) [PMID:8573421]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Tiludronate. (2006) pubmed
- Tiludronate. A new treatment for an old ailment: Paget's disease of bone. (1999) pubmed
- Tiludronate: bone pharmacology and safety. (1995) pubmed
- Skeletal safety of tiludronate. (1995) pubmed
- Pharmacokinetics of tiludronate in horses: A field population study. (2018) pubmed
- Tiludronate inhibits prostaglandin F2alpha-induced vascular endothelial growth factor synthesis in osteoblasts. (2005) pubmed
- Oral tiludronate: pharmacological properties and potential usefulness in Paget's disease of bone and osteoporosis. (1992) pubmed
- Tiludronate: development as an osteoporosis therapy. (1995) pubmed
- Tiludronate and clodronate do not affect bone structure or remodeling kinetics over a 60 day randomized trial. (2018) pubmed
- Effect of intravenous tiludronate disodium administration on the radiographic progression of osteoarthritis of the fetlock joint in Standardbred racehorses. (2021) pubmed